Stockreport

BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

BridgeBio Oncology Therapeutics, Inc.  (BBOT) 
PDF SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical compa [Read more]